BeiGene has announced that its Tevimbra (tislelizumab) has been approved by the European Commission (EC) as part of a ...

Private equity firm Apiary Capital has completed its investment into life sciences performance marketing and specialist ...

Gene therapy has the potential to change lives, slowing or stopping disease progression or even correcting symptoms entirely, ...

The answer is yes, pharma can have an impact We can and should use our expertise and resources to tackle misinformation.

AstraZeneca (AZ) and Daiichi Sankyo have shared positive results from a late-stage study of their HER2-directed antibody drug ...

The US Food and Drug Administration (FDA) has announced that all its centres will operate on a common generative artificial ...

AstraZeneca (AZ) has announced that its Bruton’s tyrosine kinase (BTK) inhibitor Calquence (acalabrutinib) has been approved ...

Tiziana Life Sciences has announced promising results from an open-label study of its investigational multiple sclerosis (MS) ...

Eli Lilly will be licensing Alchemab Therapeutics’ preclinical programme for amyotrophic lateral sclerosis (ALS) and other ...

Connected patches can be used to monitor vital patient parameters in real time, including heart rate, oxygen saturation, ...

The network has introduced a new agency and aligned its medical communications, medical affairs and publications capabilities ...

AZ’s triple-combination therapy is already approved under the brand names Breztri Aerosphere and Trixeo Aerosphere to treat ...